Abstract:Positive circumferential resection margin (CRM) was associated with a higher recurrence rate and worse survival in rectal cancer. Predictors of CRM in rectal cancer have widely been investigated. Our study aims to determine the incidence, predictors and prognostic implications of positive CRM following colon cancer (CC) surgery in a Chinese high-volume cancer center. The clinicopathological features and oncological outcomes of CC patients undergoing surgery between January 2008 and December 2018 were identified from Fudan University Shanghai Cancer Center database. Positive CRM was defined as resection margin ≤1 mm. A total of 5268 stage I-IV CC patients were identified in our study, 108 (2.05%) of whom had positive CRM. Multivariate logistic analysis found that advanced N stage, distant metastases and poorly differentiated tumor had increased risk of positive CRM. After propensity score matching, the 5-year overall survival rates of the patients with positive and negative CRM were 33.2% and 39.8% (P=0.005), respectively. Multivariable COX regression model showed that positive CRM was an independent prognostic factor for OS in CC patients. The overall rate of positive CRM in our center is lower than that in western population. Several adverse pathological parameters deserve more attention to identify CC patients at a high risk of positive CRM. Adoption of appropriate surgical techniques and multidisciplinary treatment planning are expected to improve oncological outcomes for high selected CC patients with "high-risk" CRM involvement.

Advancements and challenges in standardized pathologic assessment in rectal cancer

[Pathological Evaluation after Preoperative Neoadjuvant Treatment in Rectal Cancer].

Preoperative evaluation of the resectability of low rectal cancer

Improvement of Standardization and Accuracy of Medical Imaging and Pathological Diagnosis for Better Diagnosis and Treatment of Rectal Cancer

Incidence, Predictors and Prognostic Implications of Positive Circumferential Resection Margin in Colon Cancer: A Retrospective Study in a Chinese High-Volume Cancer Center.

Update on the surgical pathology standards on rectal cancer diagnosis, staging and quality assessment of surgery

[Standardized Examination and Research Advancement of Circumferential Resection Margin in Patients with Middle-Lower Rectal Cancer].

Changing Patterns of Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Narrative Review

The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment

Current Status of Diagnosis and Management of Rectal Cancer in China

The role of pathologists in the quality control of diagnosis and treatment of rectal cancer—an overview

Re-examination of the Standardization of Colon Cancer Surgery

Standardized pathological diagnostic process for gastric cancer and existent problems

Multidisciplinary Assessment: a New Concept for Treatment of Rectal Cancer

Problems and Countermeasures of Standardized Surgical Treatment for Colorectal Cancer

Decoding of the imaging and pathological diagnosis standard of rectal cancer

The role of postoperative pathological staging for adjuvant arrangement and prognosis evaluation of rectal cancer

Several Critical Issues of Low Rectal Cancer Surgery

Give Attention to Both Minimally Invasive Surgery and Precision Medicine to Promote the Scientificality on Individualized Clinical Practice of Rectal Cancer

Current status of surgical treatment of rectal cancer in China

[Re-Evaluation of the Clinical Significance of TNM Staging of Mid-Low Rectal Cancer].